Search for content, post, videos

Category

Acquisition

solbu
0 COMMENT
20 Views
The new Teva grows stronger – in Norway

In August last year Teva completed its acquisition of Actavis Generics and the new Teva in Norway will be among the 15 largest companies in the country. The new company will be named Teva and will be located at Teva’s facilities in Hagaløkkveien in Asker. Employees from Actavis moved in…

polypeptide
0 COMMENT
0 Views
PolyPeptide completes acquisition of Lonza’s peptides business

The PolyPeptide Group has announced that the acquisition of the peptides business and operations of Lonza in Braine-l’Alleud, Belgium has been completed. The Braine facility, with approximately 280 employees, was the center for peptide chemical development and manufacturing within Lonza. The acquisition will enhance PolyPeptide’s manufacturing capacity and capabilities and will…

magnus-groth-sca
0 COMMENT
7 Views
SCA to acquire BSN Medical

SCA has entered into an agreement to acquire BSN medical, a medical solutions company, from the private equity group EQT. BSN medical develops, manufactures, markets and sells products within wound care, compression therapy and orthopedics. The purchase price amounts to EUR 2,740m on a debt- and cash-free basis. The completion…

cmc-biologics
0 COMMENT
4 Views
AGC Asahi Glass acquires CMC Biologics

Danish CDMO CMC Biologics and AGC Asahi Glass (AGC), a world-leading manufacturer of glass, chemicals and high-tech materials, have entered into a definitive agreement with CMC Biologics’ shareholders including Monitor Clipper Partners, European Equity Partners and Innoven Partenaires, by which AGC will acquire 100% of CMC Biologics’ shares. “With the…

niklas_prager_medivir
0 COMMENT
1 Views
Karo Pharma acquires BioPhausia

Medivir has entered into an agreement with Karo Pharma regarding the sale of its subsidiary BioPhausia. The purchase price will be SEK 908 million on a cash and debt free basis, including a normalized working capital an the transaction is expected to close by mid-December 2016. As previously communicated the Board…

money sek
0 COMMENT
0 Views
GE raises bid for Arcam

General Electric on Thursday raised its recommended bid for Arcam to value the Swedish 3D printer maker at 6.2 billion crowns ($696 million), a day after abandoning its planned takeover of Germany’s SLM Solutions. GE lifted its bid to 300 crowns per share from 285 crowns. The U.S. industrial conglomerate,…

mark_mallon
0 COMMENT
1 Views
AZ enters agreement with Cilag

AstraZeneca has entered into an agreement with Cilag GmbH International, an affiliate of Johnson & Johnson, for the divestment of the rights to Rhinocort Aqua outside the US. Rhinocort Aqua is a nasal spray indicated for allergic and non-allergic rhinitis (inflammation of the inside of the nose), and for the…

luke miels
0 COMMENT
5 Views
AZ sells antibiotics business to Pfizer

AstraZeneca has announced that it has entered into an agreement with Pfizer to sell the commercialisation and development rights to its late-stage small molecule antibiotics business in most markets globally outside the US. Under the terms of the agreement, Pfizer will make an upfront payment to AstraZeneca of $550 million…

Heather_Bresch_Photo_Mylan
0 COMMENT
11 Views
Mylan completes acquisition of Meda

Earlier this month Mylan announced that it has completed the settlement of its recommended public offer to the shareholders of Meda Aktiebolag to tender all their shares in Meda to Mylan. The offer was accepted by shareholders holding approximately 94% of the total number of outstanding shares and votes in Meda,…

bristol_myers_squibb
0 COMMENT
0 Views
BMS acquires Cormorant Pharmaceuticals

Bristol-Myers Squibb has acquired all of the outstanding capital stock of Cormorant, a private, Stockholm, Sweden-based pharmaceutical company focused on the development of therapies for cancer and rare diseases. The acquisition gives Bristol-Myers Squibb full rights to Cormorant’s HuMax-IL8 antibody program and the lead candidate HuMax-IL8, a Phase 1/2 monoclonal…

peter nählstedt probi
0 COMMENT
2 Views
Probi acquires Nutraceutix

Probi to acquire Nutraceutix, strongly expanding its North American presence and capabilities, and announces rights issue of ca SEK 600 million. Swedish Probi has announced that its US subsidiary Probi USA has signed an asset purchase agreement under which Probi will acquire the operations of the US probiotic company TNTGamble, doing business as Nutraceutix,…

anders rylander biovica
0 COMMENT
2 Views
Biovica acquires cSens

Biovica has acquired cSens, a company that has developed a PCR-based platform for the analysis of serum thymidine kinase (TK) enzyme activity, which correspond to tumor proliferation and cancer aggressiveness. The cSens technology complements Biovica’s current TK assay DiviTum ™, which is currently included in clinical studies with leading cancer…

Lena Söderström Senzime
0 COMMENT
2 Views
Senzime acquires Acacia Designs

Swedish Senzime has entered into an agreement to acquire Acacia Designs BV, an international development company within anesthesia monitoring. The acquisition will be financed by 16,076,730 newly issued shares in Senzime through a non-cash issue. After the acquisition, Acacia’s shareholders will own 50 percent of the shares in Senzime. In…

diamyd vial
0 COMMENT
0 Views
Diamyd increases investment in Cellaviva

Diamyd Medical has announced that the company has increased its investment in the associated company Cellaviva with an additional SEK 1.3 million. The investment is made within the framework of a convertible loan of SEK 2.7 million, mainly directed at existing shareholders. The convertible loan will, among others, be used to finance…

AstraZeneca
0 COMMENT
0 Views
AZ explore potential takeover of Medivation

The Sunday Times reports that AstraZeneca has held “internal talks” regarding a potential bid for Medivation, but the company has not yet made a formal proposal, reported the magazine and citing unnamed sources. According to the newspaper, AstraZeneca has been tracking Medivation for the past six months, while a senior healthcare…

money sek
0 COMMENT
0 Views
Xvivo makes recommended public bid for Vivoline

The Swedish company Xvivo Perfusion has made a recommended public offer to holders of shares in Vivoline Medical. The company offers for every share in Vivoline 1.2921 Swedish crown in cash and 0.1543 shares in Xvivo Perfusion. The consideration corresponds to a value of about 9.32 Swedish crowns per share. The company…